Prelude Therapeutics, Inc. (PRLD)
3.89
+0.01
(+0.26%)
USD |
NASDAQ |
Oct 09, 16:00
3.96
+0.07
(+1.80%)
After-Hours: 20:00
Prelude Therapeutics Price : 3.89 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 3.87 | 4.03 | 3.85 | 3.89 | 341648.0 |
| Oct 08, 2026 | 3.77 | 3.95 | 3.66 | 3.88 | 424098.0 |
| Oct 07, 2026 | 3.835 | 3.93 | 3.69 | 3.83 | 454698.0 |
| Oct 06, 2026 | 3.78 | 3.82 | 3.68 | 3.81 | 383739.0 |
| Oct 05, 2026 | 3.68 | 3.81 | 3.55 | 3.77 | 325275.0 |
| Oct 02, 2026 | 3.75 | 3.815 | 3.63 | 3.67 | 742041.0 |
| Oct 01, 2026 | 3.90 | 3.940 | 3.59 | 3.79 | 502503.0 |
| Sep 30, 2026 | 4.02 | 4.02 | 3.86 | 3.91 | 703218.0 |
| Sep 29, 2026 | 3.95 | 4.00 | 3.83 | 3.96 | 458490.0 |
| Sep 28, 2026 | 3.845 | 3.98 | 3.72 | 3.91 | 496451.0 |
| Sep 25, 2026 | 4.00 | 4.05 | 3.83 | 3.875 | 336232.0 |
| Sep 24, 2026 | 4.31 | 4.32 | 3.862 | 3.99 | 1.040M |
| Sep 23, 2026 | 4.85 | 4.87 | 4.162 | 4.31 | 704937.0 |
| Sep 22, 2026 | 4.70 | 4.91 | 4.63 | 4.85 | 424587.0 |
| Sep 21, 2026 | 4.88 | 4.905 | 4.69 | 4.70 | 392657.0 |
| Sep 18, 2026 | 4.58 | 4.87 | 4.51 | 4.87 | 1.165M |
| Sep 17, 2026 | 4.79 | 4.91 | 4.49 | 4.57 | 533876.0 |
| Sep 16, 2026 | 4.55 | 4.65 | 4.36 | 4.47 | 191573.0 |
| Sep 15, 2026 | 4.56 | 4.58 | 4.40 | 4.52 | 263318.0 |
| Sep 14, 2026 | 4.60 | 4.68 | 4.50 | 4.59 | 275345.0 |
| Sep 11, 2026 | 4.72 | 4.750 | 4.56 | 4.59 | 520540.0 |
| Sep 10, 2026 | 5.04 | 5.22 | 4.64 | 4.67 | 562216.0 |
| Sep 09, 2026 | 5.25 | 5.34 | 5.06 | 5.09 | 311983.0 |
| Sep 08, 2026 | 5.38 | 5.46 | 5.19 | 5.30 | 257890.0 |
| Sep 04, 2026 | 5.19 | 5.519 | 5.19 | 5.46 | 400285.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Q32 Bio, Inc. | 8.34 |
| Intellia Therapeutics, Inc. | 13.07 |
| Twist Bioscience Corp. | 159.78 |
| Beam Therapeutics, Inc. | 25.70 |
| Revolution Medicines, Inc. | 189.76 |
Price Related Metrics
| PS Ratio | 13.88 |
| Price to Book Value | 2.32 |
| Earnings Yield | -20.25% |
| Market Cap | 310.26M |